Literature DB >> 8759758

IL-1 beta activation in human epidermis.

E Nylander-Lundqvist1, O Bäck, T Egelrud.   

Abstract

IL-1 beta is produced as an inactive 31-kDa precursor processed to active 18-kDa IL-1 beta by proteolytic cleavage, catalyzed by the highly specific IL-1-converting enzyme (ICE). In vitro activation of IL-1 beta can also be obtained by other proteases. Human keratinocytes express IL-1 beta, but not active ICE. The role played by IL-1 beta produced by keratinocytes has therefore been unclear. We asked whether normal human plantar stratum corneum contains biologically active IL-1 beta and, if so, by which mechanism this IL-1 beta is activated. Crude extracts and partially purified preparations from which IL-1 alpha had been removed were used. Biologic IL-1 activity was measured as the ability to induce expression of E-selectin in HUVEC. The crude extract contained IL-1-like activity that could be partially abolished with Abs to IL-1 alpha or IL-1 beta and totally inhibited with a mixture of the two Abs. IL-1 activity in the partially purified preparation was totally inhibited by Abs to IL-1 beta. The specific IL-1 beta activity in the two preparations was 60 to 85% of the sp. act. of recombinant human IL-1 beta. IL-1 beta from plantar stratum corneum had a slightly higher molecular mass than recombinant mature IL-1 beta. Its isoelectric point was approximately 6.1 compared with 6.9 for rIL-1 beta. We conclude that human plantar stratum corneum contains biologically active IL-1 beta that has been activated by an alternative mechanism that does not involve ICE. This is, to our knowledge, the first report of an alternative mechanism of IL-1 beta activation occurring in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759758

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  What is the 'true' function of skin?

Authors:  C M Chuong; B J Nickoloff; P M Elias; L A Goldsmith; E Macher; P A Maderson; J P Sundberg; H Tagami; P M Plonka; K Thestrup-Pederson; B A Bernard; J M Schröder; P Dotto; C M Chang; M L Williams; K R Feingold; L E King; A M Kligman; J L Rees; E Christophers
Journal:  Exp Dermatol       Date:  2002-04       Impact factor: 3.960

Review 2.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

Review 3.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

4.  Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis.

Authors:  Peter M Elias
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 5.  "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

Authors:  Peter M Elias; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2008-05       Impact factor: 8.551

Review 6.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 7.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

8.  Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis.

Authors:  Jacquelyn Levin; Sheila Fallon Friedlander; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

9.  Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms.

Authors:  A A Baqui; T F Meiller; J J Chon; B F Turng; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

10.  pH-regulated mechanisms account for pigment-type differences in epidermal barrier function.

Authors:  Roshan Gunathilake; Nanna Y Schurer; Brenda A Shoo; Anna Celli; Jean-Pierre Hachem; Debra Crumrine; Ganga Sirimanna; Kenneth R Feingold; Theodora M Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.